The bulk of these records consists of reports and other documents created between 1968
and 1970 relative to Laetrile (amygdalin) and its application in treatment and prevention
of cancer. Of the publications itemized below, writings by Dr. Ernst T. Krebs, Jr. appear
in items 2, 3, 5, 13 and 14; references to Dr. Krebs or his work appear in items 1, 4, 10
and 12.

Background

The McNaughton Foundation is a non-profit organization which sponsors scientific research
and which "seeks to encourage the creative scientific atmosphere in which the researcher
follows his own lines of investigation toward the solution of his problem, even if these
lines are in opposition to prevailing scientific or political opinion." Its director,
Andrew R. L. McNaughton, is a general consultant specializing in international affairs.
The foundation sponsors research projects dealing with mental health, the aging process,
cancer, heart disease and diabetes. An advisory board, made up of distinguished
scientists from Europe and North America, advises the foundation's director in the
disposition of funding and identification of projects worthy of support. Of interest in
this regard is the presence of Dr. Ernst T. Krebs, Jr., on the advisory board; he is
listed as a board member in documents (found in folder 2) from 1968 and 1975. The 1975
document states: "Dr. Krebs is a discoverer of Vitamins B-15 and B-17 and a number of
other substances whose development the foundation is sponsoring."